Euro
USD
British Pound
NULL
Product Description
SARS-CoV-1 Pseudovirus | 95-204 | ProSci
Product Type: Pseudovirus
Research Area: Infectious Disease, COVID-19
Host Species: N/A
Species Reactivity: N/A
Homology: N/A
Immunogen: N/A
Tested Application: Neut, Viral Infection
Predicted MW: N/A
Purification: N/A
Clonality: N/A
Clone: N/A
Isotype: N/A
Conjugate: N/A
Physical State: Liquid
Buffer: DMEM/10% FBS
Concentration: N/A
Storage: The pseudovirus is stable in a liquid state at -70˚ for 12 months. Avoid repeated freeze-thaw cycles.
Additional Names: Spike glycoprotein Receptor-binding domain, S glycoprotein, Spike protein, Delta variant spike, Delta variant pseudovirus, Delta, pseudovirus reporter, reporter virus particle
Background: SARS-CoV-1 Pseudovirus uses HIV pseudotyped with SARS-CoV-1 spike protein and firefly luciferase reporter. This pseudovirus effectively infects human ACE2 overexpressing cells and can be used to screen for inhibitors of Spike-ACE2 interaction, determine neutralizing antibody titers, and is a valuable tool for COVID-19 vaccine development as well.
Shipping Condition: Dry Ice
Source: HEK293 cells
Species: SARS-CoV-2 (COVID-19) Spike pseudovirus
Peptide Location: N/A
By Source: Human Cells
By Species: Other
Recombinant Protein Sequence: SARS-CoV-1 Spike Met 1 - Cys 1236
Badges: New
